What is InnFocus?
InnFocus, Inc. is a medical device company dedicated to developing advanced ocular solutions, with a primary focus on the treatment of glaucoma. The company's proprietary technology centers around SIBS (Segmented Ingrowth Bio-compatible Scaffold), a biostable polymer designed for surgical implants. This innovative material aims to improve patient outcomes by providing a more effective and safer approach to glaucoma management. InnFocus's mission is to enhance the quality of life for individuals suffering from ophthalmic conditions through cutting-edge medical technology, positioning itself as a key player in the specialized field of ophthalmology.
How much funding has InnFocus raised?
InnFocus has raised a total of $62.9M across 4 funding rounds:
Series A
$2M
Unspecified
$13.5M
Series B
$13.5M
Series C
$33.9M
Series A (2011): $2M, investors not publicly disclosed
Unspecified (2013): $13.5M led by Undisclosed
Series B (2013): $13.5M supported by Undisclosed
Series C (2015): $33.9M featuring Santen Pharmaceutical Co., Ltd and HOYA
Key Investors in InnFocus
Santen Pharmaceutical Co., Ltd
Santen Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company with a strong global presence in ophthalmology, specializing in the development and distribution of eye care products. Their investment in InnFocus highlights a strategic alignment in advancing glaucoma treatment technologies.
HOYA
HOYA is a Japanese multinational company known for its diverse range of products, including optical lenses and medical equipment. Their participation in InnFocus's funding round suggests an interest in innovative medical technologies within the broader healthcare and vision care sectors.
What's next for InnFocus?
The substantial enterprise-level backing and recent strategic investment signal a pivotal phase for InnFocus. This capital is likely to accelerate the company's product development pipeline, scale manufacturing capabilities, and expand its market reach, particularly for its glaucoma treatment solutions. With a focus on innovation and patient-centric care, InnFocus is poised to further solidify its position in the ophthalmology market, potentially leading to broader adoption of its SIBS technology and improved treatment standards for ocular diseases.
See full InnFocus company page
